You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

serologic relapse

Showing 1 - 25 of 3,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Syphilis, Latent, Serological Relapse After Treatment Trial (Benzathine Penicillin G, Doxycycline Capsule)

Not yet recruiting
  • Early Syphilis, Latent, Serological Relapse After Treatment
  • Benzathine Penicillin G
  • Doxycycline Capsule
  • (no location specified)
Oct 1, 2023

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Boston (Rituximab)

Recruiting
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 28, 2021

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)

Not yet recruiting
  • PDAC
  • +4 more
  • oncological relevance of the mesopancreas
  • Duesseldorf, Germany
    University Hospital Duesseldorf, Heinrich Heine University
May 30, 2023

Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)

Recruiting
  • Germ Cell Tumor
  • +2 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Dec 20, 2022

INSIGHT (Insight Into Nephrotic Syndrome)

Recruiting
  • Nephrotic Syndrome
    • Brampton, Ontario, Canada
    • +3 more
    Mar 10, 2021

    Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

    Recruiting
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Depletion of CD3/CD19 in an autologous stem cell transplant
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    May 23, 2022

    Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

    Not yet recruiting
    • Hepatitis B, Chronic
    • Shanghai, Shanghai, China
      Shanghai Tong Ren Hospital
    Nov 12, 2021

    Nasopharyngeal Carcinoma Trial in Zhongshan (participants will undergo dual-energy CT and endoscopy)

    Recruiting
    • Nasopharyngeal Carcinoma
    • participants will undergo dual-energy CT and endoscopy
    • Zhongshan, Guangdong, China
      Zhongshan People's Hospital
    May 22, 2023

    Ovarian Cancer Recurrent Trial in Czechia (DCVAC/OvCa, Standard of Care Chemotherapy)

    Completed
    • Ovarian Cancer Recurrent
    • DCVAC/OvCa
    • Standard of Care Chemotherapy
    • Brno, Czechia
    • +7 more
    Apr 20, 2021

    Description of Immunologic, Enzymatic and Metabolic Biomarkers

    Recruiting
    • Covid19
    • Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection.
    • Blood collection at 1st injection of vaccine against COVID-19, at at second injection of vaccine, at Month 1, Month 2, Month 6 and Month 12 after second injection of vaccine for volunteers
    • Poitiers, France
      C.H.U.de Poitiers
    Jun 22, 2022

    Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)

    Completed
    • Human Metapneumovirus and Human Parainfluenza Infection
    • mRNA-1653
    • Placebo
    • Birmingham, Alabama
    • +18 more
    Feb 2, 2023

    SARS-CoV-2 IgG and IgM Serologic Assays

    Active, not recruiting
    • Covid19
    • Serologic assays for antibodies to SARS-CoV-2
    • Detroit, Michigan
      Henry Ford Health System
    Dec 13, 2022

    Antibiotic Exposure in Early Infancy on Vaccine Responses

    Recruiting
    • Immune Responses
    • Antibiotic Treatment
    • Antibiotic treatment
    • Reykjavík, Iceland
      Landspitali University Hospital
    Oct 6, 2023

    Rheumatologic Disorder, IBD, Immune Complex Diseases Trial in East Setauket (Influenza vaccine)

    Completed
    • Rheumatologic Disorder
    • +2 more
    • Influenza vaccine
    • East Setauket, New York
      Clinical Research Center
    Feb 23, 2022

    Gastroenteritis Trial in Rolling Hills Estates, Stockbridge (HIL-214)

    Recruiting
    • Gastroenteritis
    • HIL-214
    • Rolling Hills Estates, California
    • +1 more
    Aug 2, 2023

    Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

    Completed
    • Idiopathic Membranous Nephropathy
    • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
    • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
    • Paris, France
      Department of Nephrology , Tenon hospital - APHP
    Oct 18, 2021

    Multiple Sclerosis Trial in Montpellier (Magnetic Resonance Imaging, Blood withdrawal, Neuropsychological tests)

    Not yet recruiting
    • Multiple Sclerosis
    • Magnetic Resonance Imaging
    • +2 more
    • Montpellier, France
      Neurology Department, Hopital Gui de Chauliac
    Jul 18, 2023

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    COVID-19 Trial in Curitiba, Rio De Janeiro, Rio de Janeiro (Covid-19 (recombinante) vaccine)

    Active, not recruiting
    • COVID-19
    • Covid-19 (recombinante) vaccine
    • Curitiba, Paraná, Brazil
    • +3 more
    Mar 23, 2022

    Precision Diagnostics in Inflammatory Bowel Disease, Cellular

    Enrolling by invitation
    • Graft Vs Host Disease
    • +2 more
      • Boston, Massachusetts
      • +1 more
      Dec 7, 2022

      Elevated Factor VIII Related Labs asBiomarker for Incomplete

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • blood tests drawn days 1, 8, 22 and 90 of the study
      • (no location specified)
      Jun 22, 2023

      Substance Use Disorders Trial in Alexandria (Mindfulness-Based Relapse Prevention program)

      Recruiting
      • Substance Use Disorders
      • Mindfulness-Based Relapse Prevention program
      • Alexandria, Egypt
        Faculty of Nursing
      Aug 11, 2023

      Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (18F-fluciclovine PET Scan)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • 18F-fluciclovine PET Scan
      • New Orleans, Louisiana
        Tulane Cancer Center Clinic
      Oct 8, 2021

      Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Nivolumab, IV, 240 mg
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 3, 2023